At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 13 enrolled
Drug / intervention
magnetic therapy protocol A +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Double-blind, Placebo-controlled Evaluation of the Application of Magnetic Fields Using the Resonator Device for the Treatment of Fibromyalgia: Pilot Study Protocol
In Brief
A Phase 2 clinical trial evaluating magnetic therapy protocol A, magnetic therapy Protocol B, and 1 other intervention for Fibromyalgia. Completed, enrolled 13 participants.
Detailed Summary
The purpose of this study is to see if a device called the Resonator can help to reduce pain and improve aspects of health and quality of life for people with fibromyalgia.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsFibromyalgia
Countries--
Collaborators--
Timeline
Phase 2CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartDec 2010
First PostedDec 2010
Primary CompletionMay 2011
TodayJul 2026
First PostedDec 17, 2010
Enrollment StartDec 1, 2010
Primary CompletionMay 1, 2011
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 15.5 years ago
Interventions
magnetic therapy protocol Adevice
Application of magnetic fields using the Resonator device Protocol A
magnetic therapy Protocol Bdevice
Application of magnetic fields using the Resonator device Protocol B
placebo therapydevice
Application of inactive magnetic fields using the Resonator device